By Emily C. Kelly-Castro On October 2, 2019, I attended the iJOBS Simulation: How to be a technical specialist. So, what does it mean to be a technical specialist you ask? A technical specialist works closely with patent lawyers to advise on specific patents.
Written by Monal Mehta On September 25th 2019, Rutgers iJOBS held an Equity Research Simulation event. Two individuals, both from Guggenheim Securities, LLC, came down from NYC for the evening to give students more insight on what an equity research career might entail. The first speaker, Charles Zhu, Ph.D., is an Equity Research Senior Associate covering small- and mid-cap Biotechnology stocks with a focus in oncology. Before obtaining this position, Dr. Zhu worked as a biopharmaceutical market access and strategy consultant at The Dedham Group. Dr.
By Janaina Pereira and Tomas Kasza
“There is a sea of data and it might be useful to learn how to sail on it.”
By Tomas Kasza The BioPharma Networking Group (BPNG) held a networking event between current and former graduate trainees in Piscataway, New Jersey on September 10, 2019. It was a great opportunity for current graduate student to get acquainted with industry professionals, industry careers and create networking bonds. The iJOBS blog caught up with several of the attendees to hear them tell their stories and experiences.
By Janaina Pereira
Phone
(732) 235-8670
Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.
Additional education text
this will be an inline link shown in the body of this section
Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
this will be an inline link shown in the body of this section
Phone
(732) 235-8670
Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.
Additional education text
this will be an inline link shown in the body of this section
Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
this will be an inline link shown in the body of this section
Phone
(732) 235-8670
Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.
Additional education text
this will be an inline link shown in the body of this section
Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
this will be an inline link shown in the body of this section
Phone
(732) 235-8670
Dr. Abali's research focuses primarily on cancer research, biochemistry, and pharmacology. More specifically, much of her work seeks to understand connections among drug resistance and targeting folate metabolism for cancer treatment. Her research background includes postdoctoral research at the Memorial Sloan Kettering Cancer Center, Columbia University, and Bilkent University. Most recently, Dr. Abali is working on translational regulation of dihydrofolate reductase. She and her team are investigating whether regulating DHFR levels through translational regulation relief can increase BH4 bioavailability and restore eNOS function. The goal is to test promising compounds that are effective in our vitro system in vivo experimental models.
Additional education text
this will be an inline link shown in the body of this section
Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Donec sollicitudin molestie malesuada. Nulla porttitor accumsan tincidunt. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Proin eget tortor risus. Mauris blandit aliquet elit, eget tincidunt nibh pulvinar a. Donec sollicitudin molestie malesuada. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui.
this will be an inline link shown in the body of this section